Ironwood Pharmaceuticals, Inc. (IRWD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.61-0.02 (-0.15%)
At close: 4:00 PM EDT
People also watch:
INFIAEGRRPTPSGYPANAC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open13.67
Prev Close13.63
Bid12.69 x 100
Ask13.77 x 4000
Day's Range13.45 - 13.76
52wk Range7.35 - 14.78
1y Target EstN/A
Market Cap1.98B
P/E Ratio (ttm)-20.22
Beta0.66
Volume391,868
Avg Vol (3m)1,158,165
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube7 hours ago

    ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube19 days ago

    ETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 10, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
    Capital Cube20 days ago

    Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016

    Categories: Yahoo Finance Click here to see latest analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, Astrazeneca PLC Sponsored ADR, Nektar Therapeutics and Cumberland Pharmaceuticals Inc. (PGNX-US, SCMP-US, AZN-US, NKTR-US ... Read more (Read more...)